PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios

Acurx Pharmaceuticals, Inc. (ACXP)

Equity · Currency in USD · Last updated Oct 3, 2023
SummaryFinancials

Company Info

ISINUS00510M1045
CUSIP00510M104
SectorHealthcare
IndustryBiotechnology

Highlights

Market Cap$24.06M
EPS-$1.11
Year Range$1.17 - $4.61
Target Price$11.33
Short %0.07%
Short Ratio0.16

Share Price Chart


Loading data...

Performance

The chart shows the growth of an initial investment of $10,000 in Acurx Pharmaceuticals, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-60.00%-40.00%-20.00%0.00%20.00%MayJuneJulyAugustSeptemberOctober
-60.06%
4.47%
ACXP (Acurx Pharmaceuticals, Inc.)
Benchmark (^GSPC)

S&P 500

Compare to other instruments

Search for stocks, ETFs, and funds to compare with ACXP

Acurx Pharmaceuticals, Inc.

Return

Acurx Pharmaceuticals, Inc. had a return of -64.57% year-to-date (YTD) and -54.52% in the last 12 months.


PeriodReturnBenchmark
1 month-23.78%-5.04%
6 months-59.13%4.21%
Year-To-Date-64.57%11.29%
1 year-54.52%16.17%
5 years (annualized)-53.42%0.04%
10 years (annualized)N/AN/A

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
20234.53%-13.58%3.68%-14.52%-23.40%-4.93%-22.28%

Risk-Adjusted Performance

This table presents a comparison of risk-adjusted performance metrics for Acurx Pharmaceuticals, Inc. (ACXP) and S&P 500 (^GSPC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratioSortino ratioOmega ratioCalmar ratioUlcer Index
ACXP
Acurx Pharmaceuticals, Inc.
-0.88
^GSPC
S&P 500
1.04

Sharpe Ratio

The current Acurx Pharmaceuticals, Inc. Sharpe ratio is -0.88. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.


Rolling 12-month Sharpe Ratio-1.00-0.500.000.501.00MayJuneJulyAugustSeptemberOctober
-0.88
0.87
ACXP (Acurx Pharmaceuticals, Inc.)
Benchmark (^GSPC)

Dividend History


Acurx Pharmaceuticals, Inc. doesn't pay dividends

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-80.00%-60.00%-40.00%-20.00%0.00%MayJuneJulyAugustSeptemberOctober
-82.13%
-10.91%
ACXP (Acurx Pharmaceuticals, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below shows the maximum drawdowns of the Acurx Pharmaceuticals, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Acurx Pharmaceuticals, Inc. is 82.13%, recorded on Sep 27, 2023. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-82.13%Jun 28, 2021565Sep 27, 2023

Volatility Chart

The current Acurx Pharmaceuticals, Inc. volatility is 18.87%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


5.00%10.00%15.00%20.00%25.00%MayJuneJulyAugustSeptemberOctober
18.87%
3.15%
ACXP (Acurx Pharmaceuticals, Inc.)
Benchmark (^GSPC)